A Thin-Layer Chromatography Bioautographic Assay for the Rapid Detection of Arachidonate 5-Lipoxygenase Inhibitors

Arachidonate 5-lipoxygenase (ALOX5) is a key enzyme implicated in several inflammatory disorders, including asthma and allergic rhinitis. Despite its therapeutic importance, only one compound is currently approved as an ALOX5 inhibitor in the United States, highlighting the urgent need for new drug candidates. Progress in this area is often hindered by conventional bioassays, which can be labor-intensive, costly, and unsuitable for complex mixtures. To overcome these challenges, we developed a simple thin-layer chromatography (TLC) bioautographic assay for the rapid detection of ALOX5 inhibitors in natural extracts, a rich source of pharmacologically active compounds. The method exploits the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone (MBTH) with 3-(dimethylamino)benzoic acid (DMAB) during the ALOX5-catalyzed conversion of arachidonic acid, producing a colored indamine dye. Experimental parameters influencing chromogenic reaction were investigated and optimized to minimize reagent consumption while ensuring accuracy and sensitivity of the method. The assay was then applied to a panel of natural products and to crude mushroom extracts, enabling the rapid identification of several active compounds within complex extracts, including the dual COX2/ALOX5 inhibitor 3α-acetylpolyporenic acid A. Easy to implement, cost-efficient, and well suited for screening and bioguided fractionation, this TLC bioassay provides a powerful tool to accelerate the discovery of novel anti-inflammatory compounds.